PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $34,000 | -94.3% | 11,940 | -93.5% | 0.00% | -91.2% |
| Q4 2019 | $592,000 | -47.2% | 182,510 | -64.9% | 0.03% | -35.8% |
| Q3 2019 | $1,122,000 | -34.6% | 519,315 | -5.0% | 0.05% | -30.3% |
| Q2 2019 | $1,716,000 | +342.3% | 546,487 | +424.3% | 0.08% | +406.7% |
| Q1 2019 | $388,000 | +28.5% | 104,240 | 0.0% | 0.02% | +25.0% |
| Q4 2018 | $302,000 | -76.1% | 104,240 | -77.4% | 0.01% | -69.2% |
| Q4 2017 | $1,263,000 | +742.0% | 461,100 | +2184.9% | 0.04% | +875.0% |
| Q3 2014 | $150,000 | -47.9% | 20,180 | -32.4% | 0.00% | -50.0% |
| Q2 2014 | $288,000 | +10.8% | 29,850 | -4.9% | 0.01% | +14.3% |
| Q1 2014 | $260,000 | -0.4% | 31,375 | +1.4% | 0.01% | -12.5% |
| Q4 2013 | $261,000 | – | 30,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |